最新发布

大豆增产新利器:精氨酸种子处理技术获科迪华认证

大农化网报道: 科迪华与瑞典作物营养公司Arevo近日宣布就Arginex Soy达成合作。该产品是Arevo基于精氨酸¹的种子处理剂,旨在强化根系,增加结瘤,并改善大豆长势,为种植者带来提高产量和作物抗逆能力的新手段,同时推进更可持续的种…

Epitope Editing Strategy Could Enable Less Toxic Stem Cell Transplants

Stem cell transplantation and gene therapy are among the most powerful curative approaches for blood diseases such as sickle cell disease, β-thalassemia, immune deficiencies, and some blood cancers. Replacing or correcting the blood-forming stem cells can offer the possibility of long-lasting benefit or a cure. However, before patients can receive these therapies, they usually need intensive and potentially toxic chemotherapy or radiation to clear space in the bone marrow for the new stem cells.

Global Food Safety Standards Body Codex Agrees On New Guidance On “May Contain” Allergen Labels

July 2026, Rome: The Codex Alimentarius Commission today agreed to adopt new international guidelines on the u…

Meet the 3 forces reshaping consumer palates and food industry profits

The profit structure for food and beverage companies is about to shift “on a scale that the food industry has not …

富美实意大利工厂完成唑草酮制剂首批生产,将用于荷兰市场

世界农化网中文网报道:近日,富美实公司(FMC)在其位于意大利San Colombano的生产基地完成了Spotlight® Plus 5L干燥剂(活性成分:唑草酮)的首批生产,该产品搭载了easyconnect™封闭式转移系统(CTS)。首批产品将用于在荷兰市场引入该技术。

Alchemab extends Series A with £25m from British Business Bank

Why it matters: The investment is the British Business Bank’s largest direct life sciences investment to date, and comes as the UK tries to keep more high-growth biotech companies scaling at home.

Fujifilm Selected with Six Others in FDA PreCheck Pilot Manufacturing Program

Fujifilm Biotechnologies reports that its commercial-scale cell culture manufacturing facility in Holly Springs, NC, has been selected as one of only seven participants in the FDA’s PreCheck Pilot Program. The program, which also includes Amneal Pharmaceutical, Cellares, Eli Lilly, Kriya Therapeutics, Kyowa Kirin, and Regeneron, is a strategic initiative designed to strengthen America’s pharmaceutical manufacturing capabilities and help accelerate patient access to critical medicines.

AZ buys ex-China rights to Sino’s COPD drug for $2.1bn

By the numbers: UK-based AstraZeneca is paying $200 million upfront plus $1.9 billion for the PDE 3/4 inhibitor TQC3721. The deal also includes tiered royalties ranging up to double-digit percentages based on the annual net sales of TQC3721 products.

科迪华提供原药、Crystal负责制剂开发与市场:双方共拓印度植保市场

世界农化网中文网报道:近日,Crystal Crop Protection Limited与科迪华签署合作协议,双方将在印度市场共同开发并商业化新型作物保护制剂和混配产品。根据协议,两家公司将合作进行产品开发、生产和商业化推广。

Olam Agri on what it takes to build self-reliant food systems across Africa

Africa has long been a part of the heritage and growth strategy for global agribusiness giant Olam Agri, which has opera…